Bacillus Calmette–Guérin vaccine, antimalarial, age and gender relation to COVID-19 spread and mortality

•COVID-19 is affecting different countries all over the world with great variation in infection rate and death ratio.•Some reports suggested a relation between the Bacillus Calmette-Guérin (BCG) vaccine and the malaria treatment to the infection prevention.•Some reports related infant's lower-s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2020-07, Vol.38 (35), p.5564-5568
Hauptverfasser: Osama El-Gendy, Ahmed, Saeed, Haitham, Ali, Ahmed M.A., Zawbaa, Hossam M., Gomaa, Dina, Harb, Hadeer S., Madney, Yasmin M., Osama, Hasnaa, Abdelrahman, Mona A., Abdelrahim, Mohamed E.A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:•COVID-19 is affecting different countries all over the world with great variation in infection rate and death ratio.•Some reports suggested a relation between the Bacillus Calmette-Guérin (BCG) vaccine and the malaria treatment to the infection prevention.•Some reports related infant's lower-susceptibility to the BCG vaccine. Some other reports a higher risk in males compared to females in such a COVI-19 pandemic.•Some other reports claimed the possible use of chloroquine and hydroxychloroquine as prophylactic in such a pandemic.•The-present commentary is to discuss the possible relation between those-factors and SARS-CoV-2 infection. COVID-19 is affecting different countries all over the world with great variation in infection rate and death ratio. Some reports suggested a relation between the Bacillus Calmette-Guérin (BCG) vaccine and the malaria treatment to the prevention of SARS-CoV-2 infection. Some reports related infant's lower susceptibility to the COVID-19. Some other reports a higher risk in males compared to females in such COVID-19 pandemic. Also, some other reports claimed the possible use of chloroquine and hydroxychloroquine as prophylactic in such a pandemic. The present commentary is to discuss the possible relation between those factors and SARS-CoV-2 infection.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2020.06.083